Abstract

BackgroundAs HIV-infected infants have high mortality, the World Health Organization now recommends initiating antiretroviral therapy as early as possible in the first year of life. However, in many settings, laboratory diagnosis of HIV in infants is not readily available. We aimed to develop a clinical algorithm for HIV presumptive diagnosis in infants < 10 weeks old using screening data from the Children with HIV Early Antiretroviral therapy (CHER) study in South Africa.HIV-infected and HIV-uninfected exposed infants < 10 weeks of age were identified through Vertical Transmission Prevention programs. Clinical and laboratory data were systematically recorded, groups were compared using Kruskal-Wallis, analysis of variance (ANOVA), and Fisher's exact tests. Receiver Operating Characteristic (ROC) curves were compiled using combinations of clinical findings.Results417 HIV-infected and 125 HIV-exposed, uninfected infants, median age 46 days (IQR 38-55), were included. The median CD4 percentage in HIV-infected infants was 34 (IQR 28-41)%. HIV-infected infants had lower weight-for-age, more lymphadenopathy, oral thrush, and hepatomegaly than exposed uninfected infants (Adjusted Odds Ratio 0.51, 8.8, 5.6 and 23.5 respectively; p < 0.001 for all). Sensitivity of individual signs was low (< 20%) but specificity high (98-100%). If any one of oral thrush, hepatomegaly, splenomegaly, lymphadenopathy, diaper dermatitis, weight < 50th centile are present, sensitivity for HIV infection amongst HIV-exposed infants was 86%. These algorithms performed similarly when used to predict severe immune suppression.ConclusionsA combination of physical findings is helpful in identifying infants most likely to be HIV-infected. This may inform management algorithms and provide guidance for focused laboratory testing in some settings, and should be further validated in these settings and elsewhere.

Highlights

  • As HIV-infected infants have high mortality, the World Health Organization recommends initiating antiretroviral therapy as early as possible in the first year of life

  • The Children with HIV Early Antiretroviral Therapy (CHER) trial [4] recently showed that early antiretroviral therapy (ART), commenced at a median of 7 weeks of age was associated with a 75% reduction in mortality

  • Diagnostic HIV-1 DNA PCR is recommended at 6 weeks of age in HIV-exposed infants going through Vertical Transmission Prevention (VTP) programs [8]

Read more

Summary

Introduction

As HIV-infected infants have high mortality, the World Health Organization recommends initiating antiretroviral therapy as early as possible in the first year of life. In many settings, laboratory diagnosis of HIV in infants is not readily available. We aimed to develop a clinical algorithm for HIV presumptive diagnosis in infants < 10 weeks old using screening data from the Children with HIV Early Antiretroviral therapy (CHER) study in South Africa. HIV-infected and HIV-uninfected exposed infants < 10 weeks of age were identified through Vertical Transmission Prevention programs. Diagnostic HIV-1 DNA PCR is recommended at 6 weeks of age in HIV-exposed infants going through Vertical Transmission Prevention (VTP) programs [8]. Clinical algorithms for HIV diagnosis in young infants could be useful for identifying those with probable HIV infection [9-13].

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call